CIM Investment Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $467K | Sell |
16,642
-70
| -0.4% | -$1.86K | 0.12% | 142 |
|
|
2025
Q4 | $416K | Hold |
16,712
| – | – | 0.11% | 148 |
|
|
2025
Q3 | $426K | Sell |
16,712
-17,094
| -51% | -$422K | 0.12% | 140 |
|
|
2025
Q2 | $858K | Buy |
33,806
+16,875
| +100% | +$394K | 0.16% | 119 |
|
|
2025
Q1 | $429K | Sell |
16,931
-11
| -0.1% | -$288 | 0.1% | 132 |
|
|
2024
Q4 | $449K | Sell |
16,942
-214
| -1% | -$5.8K | 0.13% | 126 |
|
|
2024
Q3 | $496K | Sell |
17,156
-654
| -4% | -$19.1K | 0.15% | 121 |
|
|
2024
Q2 | $498K | Sell |
17,810
-214
| -1% | -$5.89K | 0.15% | 124 |
|
|
2024
Q1 | $500K | Hold |
18,024
| – | – | 0.15% | 136 |
|
|
2023
Q4 | $519K | Hold |
18,024
| – | – | 0.17% | 123 |
|
|
2023
Q3 | $598K | Sell |
18,024
-370
| -2% | -$13.1K | 0.22% | 99 |
|
|
2023
Q2 | $675K | Buy |
18,394
+37
| +0.2% | +$1.44K | 0.23% | 94 |
|
|
2023
Q1 | $749K | Buy |
18,357
+9,686
| +112% | +$418K | 0.28% | 77 |
|
|
2022
Q4 | $444K | Sell |
8,671
-9,145
| -51% | -$438K | 0.17% | 125 |
|
|
2022
Q3 | $780K | Hold |
17,816
| – | – | 0.35% | 54 |
|
|
2022
Q2 | $934K | Sell |
17,816
-94
| -0.5% | -$4.79K | 0.39% | 45 |
|
|
2022
Q1 | $927K | Sell |
17,910
-18
| -0.1% | -$934 | 0.31% | 67 |
|
|
2021
Q4 | $1.06M | Sell |
17,928
-1,411
| -7% | -$69.9K | 0.32% | 59 |
|
|
2021
Q3 | $832K | Buy |
+19,339
| New | +$857K | 0.26% | 77 |
|
|
2021
Q2 | – | Sell |
-19,501
| Closed | -$707K | – | 324 |
|
|
2021
Q1 | $707K | Sell |
19,501
-761
| -4% | -$27K | 0.22% | 86 |
|
|
2020
Q4 | $746K | Sell |
20,262
-1,443
| -7% | -$52.9K | 0.24% | 79 |
|
|
2020
Q3 | $756K | Sell |
21,705
-240
| -1% | -$8.41K | 0.29% | 67 |
|
|
2020
Q2 | $681K | Sell |
21,945
-791
| -3% | -$26.9K | 0.27% | 75 |
|
|
2020
Q1 | $704K | Buy |
22,736
+816
| +4% | +$27.8K | 0.34% | 54 |
|
|
2019
Q4 | $815K | Hold |
21,920
| – | – | 0.32% | 66 |
|
|
2019
Q3 | $747K | Buy |
+21,920
| New | +$797K | 0.28% | 61 |
|
|
2019
Q2 | – | Sell |
-19,267
| Closed | -$776K | – | 339 |
|
|
2019
Q1 | $776K | Buy |
19,267
+4,410
| +30% | +$177K | 0.3% | 63 |
|
|
2018
Q4 | $615K | Sell |
14,857
-15,596
| -51% | -$647K | 0.27% | 79 |
|
|
2018
Q3 | $1.27M | Sell |
30,453
-4,591
| -13% | -$177K | 0.45% | 26 |
|
|
2018
Q2 | $1.21M | Sell |
35,044
-926
| -3% | -$31.6K | 0.42% | 32 |
|
|
2018
Q1 | $1.21M | Sell |
35,970
-833
| -2% | -$28.6K | 0.41% | 35 |
|
|
2017
Q4 | $1.26M | Sell |
36,803
-516
| -1% | -$17.6K | 0.43% | 35 |
|
|
2017
Q3 | $1.26M | Sell |
37,319
-21,245
| -36% | -$683K | 0.46% | 34 |
|
|
2017
Q2 | $1.87M | Sell |
58,564
-911
| -2% | -$28.7K | 0.66% | 17 |
|
|
2017
Q1 | $1.93M | Sell |
59,475
-5,516
| -8% | -$174K | 0.66% | 15 |
|
|
2016
Q4 | $2M | Buy |
64,991
+747
| +1% | +$22.8K | 0.73% | 15 |
|
|
2016
Q3 | $2.06M | Sell |
64,244
-4,954
| -7% | -$166K | 0.79% | 14 |
|
|
2016
Q2 | $2.31M | Sell |
69,198
-2,973
| -4% | -$94.9K | 0.96% | 10 |
|
|
2016
Q1 | $2.03M | Sell |
72,171
-9,316
| -11% | -$266K | 0.88% | 16 |
|
|
2015
Q4 | $2.5M | Hold |
81,487
| – | – | 1.14% | 13 |
|
|
2015
Q3 | $2.43M | Hold |
81,487
| – | – | 1.17% | 11 |
|
|
2015
Q2 | $2.59M | Buy |
81,487
+595
| +0.7% | +$19.4K | 1.14% | 13 |
|
|
2015
Q1 | $2.67M | Hold |
80,892
| – | – | 1.16% | 12 |
|
|
2014
Q4 | $2.39M | Hold |
80,892
| – | – | 1.1% | 18 |
|
|
2014
Q3 | $2.27M | Sell |
80,892
-3,742
| -4% | -$105K | 1.15% | 18 |
|
|
2014
Q2 | $2.38M | Sell |
84,634
-2,281
| -3% | -$65K | 1.2% | 17 |
|
|
2014
Q1 | $2.65M | Sell |
86,915
-2,025
| -2% | -$60.4K | 1.22% | 16 |
|
|
2013
Q4 | $2.58M | Buy |
88,940
+6,135
| +7% | +$179K | 1.32% | 18 |
|
|
2013
Q3 | $2.26M | Hold |
82,805
| – | – | 1.34% | 19 |
|
|
2013
Q2 | $2.2M | Buy |
+82,805
| New | +$2.29M | 1.31% | 20 |
|
Other funds holding PFE
CIM Investment Management's PFE Position: Q1 2026 in Review
CIM Investment Management reduced its Pfizer (PFE) stake by 0.42% in Q1 2026, selling an estimated $1.86K and leaving 16,642 shares worth $467K. The position accounts for 0.12% of the portfolio, ranked #142.
CIM Investment Management first reported a position in PFE in Q2 2013 and has held it in 50 quarters since. The position peaked at $2.67M in Q1 2015. 2,955 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- CIM Investment Management held 16,642 shares of Pfizer worth $467K as of Q1 2026.
- CIM Investment Management sold 70 Pfizer shares in Q1 2026, an estimated $1.86K.
- Pfizer made up 0.12% of CIM Investment Management's portfolio in Q1 2026, its #142 holding.
- CIM Investment Management first reported a position in Pfizer in Q2 2013 and has held it in 50 quarters since.
- CIM Investment Management's Pfizer position peaked at $2.67M in Q1 2015.
- 2,955 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on CIM Investment Management's 13F filing for Q1 2026, filed 19 May 2026.